Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Progress toward Health System Readiness for Genome-Based Testing in Canada

Don Husereau
* ,
Eva Villalba
ORCID logo ,
Vivek Muthu
,
Michael Mengel
,
Craig Ivany
,
Lotte Steuten
,
Daryl S. Spinner
,
Brandon Sheffield
,
Stephen Yip
,
Philip Jacobs
,
Terrence Sullivan
Version 1 : Received: 5 May 2023 / Approved: 8 May 2023 / Online: 8 May 2023 (08:36:59 CEST)

A peer-reviewed article of this Preprint also exists.

Husereau, D.; Villalba, E.; Muthu, V.; Mengel, M.; Ivany, C.; Steuten, L.; Spinner, D.S.; Sheffield, B.; Yip, S.; Jacobs, P.; Sullivan, T.; Arshoff, L. Progress toward Health System Readiness for Genome-Based Testing in Canada. Curr. Oncol. 2023, 30, 5379-5394. Husereau, D.; Villalba, E.; Muthu, V.; Mengel, M.; Ivany, C.; Steuten, L.; Spinner, D.S.; Sheffield, B.; Yip, S.; Jacobs, P.; Sullivan, T.; Arshoff, L. Progress toward Health System Readiness for Genome-Based Testing in Canada. Curr. Oncol. 2023, 30, 5379-5394.

Abstract

1) Background: Genomic medicine harbors the real potential to improve the health and healthcare jour-ney of patients, care provider experiences, and improve health system efficiency – even reducing health care costs. There is expected to be an exponential growth in medically necessary new genome- based tests and test approaches in coming years. Testing can also create scientific research and commercial opportu-nities beyond healthcare decision-making. The purpose of this research is to generate a better under-standing of Canada’s state of readiness for genomic medicine, and to provide some insights for other healthcare systems; (2) Methods: a mixed-methodsapproach of literature review and key informant in-terviews with a purposive sample of experts was used. Health system readiness was assessed using a pre-viously published set of conditions. (3) Results: Canada has created some of the established conditions but more needs to be done to improve the state of readiness for genome-based medicine. Important gaps are the need for linked information systems and data integration; evaluative processes that are timely, and transparent; navigational tools for care providers; dedicated funding to facilitate rapid onboarding and supports test development and proficiency testing; and broader engagement with a broader set of inno-vation stakeholders. These findings highlight the known role of organizational context, social influence, and other factors that are known to affect the diffusion of innovation within health systems

Keywords

diagnostic molecular pathology; genetic testing; diagnostic services; technology assess- ment; biomedical; genetic services; financial support; clinical governance; health technology; healthcare innovation

Subject

Public Health and Healthcare, Health Policy and Services

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0
Get PDF Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.